期刊文献+

经腹次全子宫切除术对子宫肌瘤患者卵巢功能及并发症的影响 被引量:3

Influence of Transabdominal Subtotal Hysterectomy on Ovarian Function and Complications in Patients with Hysteromyoma
下载PDF
导出
摘要 目的探讨经腹次全子宫切除术对子宫肌瘤患者卵巢功能及并发症的影响。方法选择2017年8月至2019年7月我院收治的子宫肌瘤患者64例,随机分为对照组(n=32)和观察组(n=32)。对照组采用经腹全子宫切除术,观察组采用经腹次全子宫切除术。对比两组的卵巢功能、生活质量及并发症情况。结果术后1个月,观察组的E2、AFC水平高于对照组,FSH、LH水平低于对照组(P均<0.05)。术后1个月,观察组的QOL评分高于对照组(P<0.05)。两组的并发症发生率(12.50%vs.18.75%)比较差异无统计学意义(P>0.05)。结论与经腹全子宫切除术相比,经腹次全子宫切除术对子宫肌瘤患者卵巢功能的影响较小,患者的生活质量较高,安全有效,值得临床推广。 Objective To explore the influence of transabdominal subtotal hysterectomy on ovarian function and complications in patients with hysteromyoma.Methods 64 cases of patients with hysteromyoma admitted to our hospital from August 2017 to July 2019 were selected and randomly divided into control group(n=32)and observation group(n=32).The control group received transabdominal hysterectomy,and the observation group received transabdominal subtotal hysterectomy.The ovarian function,quality of life and complications were compared between the two groups.Results 1 month after operation,the E2 and AFC levels of the observation group were higher than those of the control group,and the FSH and LH levels were lower than those of the control group(all P<0.05).1 month after operation,the QOL score of the observation group was higher than that of the control group(P<0.05).No statistical difference was found in the incidence of complications(12.50%vs.18.75%)between the two groups(P>0.05).Conclusions Compared with transabdominal hysterectomy,transabdominal subtotal hysterectomy has less influence on ovarian function of patients with hysteromyoma,with higher quality of life,which is safe and effective,and is worthy of clinical promotion.
作者 丁建梅 DING Jianmei(Department of Obstetrics and Gynecology,Dengzhou Hospital of Traditional Chinese Medicine,Dengzhou 474150,China)
出处 《临床医学工程》 2020年第3期329-330,共2页 Clinical Medicine & Engineering
关键词 子宫肌瘤 经腹次全子宫切除术 卵巢功能 并发症 Hysteromyoma Transabdominal subtotal hysterectomy Ovarian function Complication
  • 相关文献

二级参考文献57

  • 1Campbell J, Rajan DK, Kachura JR, et al. Efficacy of ovarian artery embolization for uterine fibroids:clinical and magnetic resonance ima- ging evaluations[J]. Can Assoc Radiol J,2015,66(2) :164 -170.
  • 2Me Pherson K, Manyonda I, Lumsden MA, et al. A randomised trial of treating fibroids with either embolisation or myomectomy to measure the effect on quality of life among women wishing to avoid hysterecto- my(the FEMME study) :study protocol for a randomised controlled trial[J]. Trials,2014,29(15) :468 -471.
  • 3~onehara ~,~anazume S,Kamio M, et al. Concentrated ascites re-in- fusion therapy for pseudo-Meigs' syndrome complicated by massive as- cites in large pedunculated uterine leiomyoma[ J]. J Obstet Gynaecol Res,2014,40 ( 7 ) : 1944 - 1949.
  • 4Moravek MB,Yin P,Ono M,et al. Ovarian steroids, stem cells and u- terine leiomyoma : therapeutic implications [ J ]. Hum Reprod Update, 2015,21(1) :1 -12.
  • 5Alsolami S, E1-Bahrawy M, Kalloger SE, et al. Current morphologic criteria perform poorly in identifying hereditary leiomyomatosis and re- nal cell carcinoma syndrome-associated uterine leiomyomas [J]. Int J Gynecol Pathol,2014,33 ( 6 ) :560 - 567.
  • 6Guo H,Zhang X,Dong R, et al. Integrated analysis of long noncoding RNAs and mRNAs reveals their potential roles in the pathogenesis of uterine leiomyomas [ J ]. Oncotarget ,2014,5 ( 18 ) : 8625 - 8636.
  • 7Oliva E. Cellular mesenchymal tumors of the uterus :a review emphasizing recent observations[ J]. Int J Gynecol Pathol,2014,33 (4) :374 -384.
  • 8Zou Y,Liu FY,Liu H,et al. Frequent POLEI p. $297 F mutation in Chinese patients with ovarian endometrioid carcinoma[ J ]. Murat Res, 2014,761 (22) :49 -52.
  • 9甄文明,邹岚,谭燕玲.腹腔镜辅助阴式全子宫切除术治疗巨大子宫肌瘤临床研究[J].当代医学,2011,17(18):69-70. 被引量:57
  • 10刘艳.腹腔镜辅助阴式全子宫切除术治疗巨大子宫肌瘤临床研究[J].中国实用医药,2012,7(24):108-109. 被引量:20

共引文献147

同被引文献41

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部